BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36909367)

  • 1. LncRNA SPRY4‑IT1 is upregulated and promotes the proliferation of prostate cancer cells under hypoxia in vitro.
    Sang W; Zhu R; Liu D; Gong M
    Oncol Lett; 2023 Apr; 25(4):138. PubMed ID: 36909367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2.
    Liu D; Li Y; Luo G; Xiao X; Tao D; Wu X; Wang M; Huang C; Wang L; Zeng F; Jiang G
    Cancer Lett; 2017 Mar; 388():281-291. PubMed ID: 27998761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SPRY4-IT1 facilitates cell proliferation and angiogenesis of glioma via the miR-101-3p/EZH2/VEGFA signaling axis.
    Wang J; Chen Y; Wang Q; Xu H; Jiang Q; Wang M; Li S; Chen Y; Wu C; Yu P; Xiao Z; Chen W; Lan Q
    Cancer Med; 2023 Mar; 12(6):7309-7326. PubMed ID: 36479622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
    Sun M; Liu XH; Lu KH; Nie FQ; Xia R; Kong R; Yang JS; Xu TP; Liu YW; Zou YF; Lu BB; Yin R; Zhang EB; Xu L; De W; Wang ZX
    Cell Death Dis; 2014 Jun; 5(6):e1298. PubMed ID: 24967960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA SPRY4-IT1 promotes proliferation and metastasis in nasopharyngeal carcinoma cell.
    Li Y; Liao Z; Wang R; Liang Z; Lin Z; Deng S; Chen L; Liu Z; Feng S
    PeerJ; 2022; 10():e13221. PubMed ID: 35378932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.
    Xu Y; Yao Y; Jiang X; Zhong X; Wang Z; Li C; Kang P; Leng K; Ji D; Li Z; Huang L; Qin W; Cui Y
    J Exp Clin Cancer Res; 2018 Apr; 37(1):81. PubMed ID: 29642935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.
    Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M
    J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference from LncRNA SPRY4-IT1 restrains the proliferation, migration, and invasion of melanoma cells through inactivating MAPK pathway by up-regulating miR-22-3p.
    Li Z; Tang X; Duan S
    Int J Clin Exp Pathol; 2019; 12(2):477-487. PubMed ID: 31933852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA SPRY4-IT1 Regulates Cell Proliferation and Migration by Sponging miR-101-3p and Regulating AMPK Expression in Gastric Cancer.
    Cao S; Lin L; Xia X; Wu H
    Mol Ther Nucleic Acids; 2019 Sep; 17():455-464. PubMed ID: 31330497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA
    Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA SPRY4-IT1 promotes cell proliferation and invasion by regulation of Cdc20 in pancreatic cancer cells.
    Guo W; Zhong K; Wei H; Nie C; Yuan Z
    PLoS One; 2018; 13(2):e0193483. PubMed ID: 29489909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long noncoding RNA SPRY4-IT1-mediated EZH2 on the invasion and migration of lung adenocarcinoma.
    Wen X; Han XR; Wang YJ; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Wu Q; Tan JH; Wu DM; Lu J; Zheng YL
    J Cell Biochem; 2018 Feb; 119(2):1827-1840. PubMed ID: 28796375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression.
    Shi Y; Li J; Liu Y; Ding J; Fan Y; Tian Y; Wang L; Lian Y; Wang K; Shu Y
    Mol Cancer; 2015 Feb; 14():51. PubMed ID: 25742952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB-activated SPRY4-IT1 promotes cancer cell metastasis by downregulating TCEB1 mRNA via Staufen1-mediated mRNA decay.
    Zhao L; Jiang L; Zhang M; Zhang Q; Guan Q; Li Y; He M; Zhang J; Wei M
    Oncogene; 2021 Jul; 40(30):4919-4929. PubMed ID: 34163032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDK1-stabilized LncRNA SPRY4-IT1 promotes breast cancer progression via activating NF-κB signaling pathway.
    Zhang Y; Chen H; Yuan R; Wang Y; Zhang D; Zeng Q; Jiang W; Zhang R; Chen T; Chai C; Guo B
    Mol Carcinog; 2023 Jul; 62(7):1009-1024. PubMed ID: 37042573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of SPRY4 and SPRY4-IT1 inhibits cell growth and phosphorylation of Akt in human testicular germ cell tumours.
    Das MK; Furu K; Evensen HF; Haugen ØP; Haugen TB
    Sci Rep; 2018 Feb; 8(1):2462. PubMed ID: 29410498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial-mesenchymal transition.
    Zhang CY; Li RK; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
    Cell Biol Toxicol; 2016 Oct; 32(5):391-401. PubMed ID: 27250657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
    Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
    Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
    Yu J; Han Q; Cui Y
    Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.